Eye cells taken from a dead donor were successfully transplanted into the brains of Parkinson's disease patients and began producing levodopa, a main chemical used in treating the affliction. Researchers reported in the Archives of Neurology that the cells were taken from the inner layer of the retina and for at least two years led to a reduction of the involuntary movements associated with Parkinson's.

Full Story:

Related Summaries